295 related articles for article (PubMed ID: 29462053)
1. Vitamin K antagonists and emergencies.
Lapostolle F; Siguret V; Martin AC; Pailleret C; Vigué B; Zerbib Y; Tazarourte K
Eur J Emerg Med; 2018 Dec; 25(6):378-386. PubMed ID: 29462053
[TBL] [Abstract][Full Text] [Related]
2. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
[TBL] [Abstract][Full Text] [Related]
3. Reversing vitamin K antagonists: making the old new again.
Eichinger S
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):605-611. PubMed ID: 27913535
[TBL] [Abstract][Full Text] [Related]
4. An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal.
Altorjay Á; Szabó É; Boda Z; Kramer L; Ngo LY; Engl W; Firth CL; Ahlstrom ER; Gelmont DM; Pabinger I
Thromb Res; 2015 Mar; 135(3):485-91. PubMed ID: 25613927
[TBL] [Abstract][Full Text] [Related]
5. Four factor prothrombin complex concentrate (human): review of the pharmacology and clinical application for vitamin K antagonist reversal.
Kinard TN; Sarode R
Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):417-27. PubMed ID: 24650310
[TBL] [Abstract][Full Text] [Related]
6. Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists?
Steib A; Barre J; Mertes M; Morel MH; Nathan N; Ozier Y; Treger M; Samama CM
J Thromb Haemost; 2010 Mar; 8(3):499-503. PubMed ID: 19912513
[TBL] [Abstract][Full Text] [Related]
7. Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.
Desmettre T; Dehours E; Samama CM; Jhundoo S; Pujeau F; Guillaudin C; Hecquart C; Clerson P; Crave JC; Jaussaud R
Crit Care; 2012 Oct; 16(5):R185. PubMed ID: 23036234
[TBL] [Abstract][Full Text] [Related]
8. Prospective Evaluation of a Fixed-Dose 4-Factor Prothrombin Complex Concentrate Protocol for Urgent Vitamin K Antagonist Reversal.
Bitonti MT; Rumbarger RL; Absher RK; Curran LM
J Emerg Med; 2020 Feb; 58(2):324-329. PubMed ID: 31787372
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
[TBL] [Abstract][Full Text] [Related]
10. Approaches to optimal dosing of vitamin K antagonists.
Witt DM
Semin Thromb Hemost; 2012 Oct; 38(7):667-72. PubMed ID: 22893509
[TBL] [Abstract][Full Text] [Related]
11. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
Lip GYH; Haguenoer K; Saint-Etienne C; Fauchier L
Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
[TBL] [Abstract][Full Text] [Related]
12. Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications.
Marcos-Jubilar M; García Erce JA; Martínez-Calle N; Páramo JA; Martínez Virto A; Quintana-Díaz M
Transfus Med; 2019 Aug; 29(4):268-274. PubMed ID: 31347218
[TBL] [Abstract][Full Text] [Related]
13. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.
Michalski F; Tittl L; Werth S; Hänsel U; Pannach S; Sahin K; Weiss N; Beyer-Westendorf J
Thromb Haemost; 2015 Nov; 114(5):1076-84. PubMed ID: 25994496
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Ansell J; Hirsh J; Hylek E; Jacobson A; Crowther M; Palareti G
Chest; 2008 Jun; 133(6 Suppl):160S-198S. PubMed ID: 18574265
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of vitamin K antagonist overcoagulation.
Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
[TBL] [Abstract][Full Text] [Related]
16. Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis.
Brekelmans MPA; Ginkel KV; Daams JG; Hutten BA; Middeldorp S; Coppens M
J Thromb Thrombolysis; 2017 Jul; 44(1):118-129. PubMed ID: 28540468
[TBL] [Abstract][Full Text] [Related]
17. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
18. The effect of administering preprocedural VITamin K on the international normalized ratio in patients anticoagulated with ACEnocoumarol (VITKACE-study): a prospective cohort study.
Bijkerk S; Lourens HJ; Mares WGN; van Kampen CA; van der Veen MJ; Adriaansen HJ; Ponfoort ED; Festen B; Westendorp GW; Rovers JMP; Groot GMC; Bootsma HR; Amelung LM; Bins S; Velders G; Bemelmans RHH
J Thromb Haemost; 2024 Jul; 22(7):1847-1856. PubMed ID: 38580096
[TBL] [Abstract][Full Text] [Related]
19. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.
Pabinger I; Brenner B; Kalina U; Knaub S; Nagy A; Ostermann H;
J Thromb Haemost; 2008 Apr; 6(4):622-31. PubMed ID: 18208533
[TBL] [Abstract][Full Text] [Related]
20. Reversal of Vitamin K Antagonist Therapy Before Thrombolysis for Acute Ischemic Stroke.
Chausson N; Soumah D; Aghasaryan M; Altarcha T; Alecu C; Smadja D
Stroke; 2018 Oct; 49(10):2526-2528. PubMed ID: 30355096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
